A Flexible Transgene Integration Landing-Pad Toolkit in Human Induced Pluripotent Stem Cells Enables Facile Cellular Engineering, Gene Zygosity Control, and Parallel Transgene Integration
Rosenstein, A. H.; Nguyen, M.; Al-attar, R.; Serra, D.; Gulati, N.; Yin, T.; Gilbert, P. M.; Garton, M.
Show abstract
Development of a repeatable method for delivering transgene payloads to human induced pluripotent stem cells (hiPSCs) without risking unintended off-target effects is not fully realized. Yet, such methods are indispensable to fully unlocking the potential for applying synthetic biological approaches to regenerative medicine, delivering quantum impacts to cell-based therapeutics development. Here we present a toolkit for engineering hiPSCs centred on the development of two core landing-pad cell-lines, facilitating rapid high-efficiency delivery of transgenes to the AAVS1 safe-harbour locus using the Bxb1 large-serine recombinase. We developed two landing-pad cell lines expressing green and red fluorescent reporters respectively, both retaining stemness whilst fully capable of differentiation into all three germ layers. A fully selected hiPSC population can be isolated within 1-2 weeks after landing-pad recombinase-mediated cassette exchange. We demonstrate the capability for investigator-controlled homozygous or heterozygous transgene configurations in these cells. As such, the toolkit of vectors and protocols associated with this landing-pad hiPSC system has the potential to accelerate engineering workflows for researchers in a variety of disciplines.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Clinically Relevant Gene Editing in Hematopoietic Stem Cells for the Treatment of Pyruvate Kinase Deficiency Hemolytic Anemia 93%
- AAV-mediated gene augmentation therapy restores critical functions in mutant iPSC-derived PRPF31+/- cells. 93%
- Screening of Chimeric GAA Variants in a Preclinical Study of Pompe Disease Results in Candidate Vector for Hematopoietic Stem Cell Gene Therapy 92%
Similar papers in this journal
- Leveraging CRISPR activation for rapid assessment of gene editing products in human pluripotent stem cells 95%
- Efficient transgenesis and homology-directed gene targeting in monolayers of primary human small intestinal and colonic epithelial stem cells 95%
- MIXL1 Activation in Endoderm Differentiation ofHuman Induced Pluripotent Stem Cells 95%
Similar papers in this journal
- Efficient installation of heterozygous mutations in human pluripotent stem cells using prime editing 94%
- Self-cutting and integrating CRISPR plasmids (SCIPs) enable targeted genomic integration of large genetic payloads for rapid cell engineering 93%
- A cellular stress response induced by the CRISPR/dCas9 activation system is not heritable through cell divisions 92%
Similar papers in this journal
- TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage 94%
- Thymidylate synthase disruption to limit cell proliferation in cell therapies 94%
- Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestations 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.